发明名称 FLUOROERGOLINE DERIVATIVES AND USES THEREOF
摘要 Provided herein are novel fluoroergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT1D and/or the 5-HT1B receptor, without agonizing the 5-HT2B receptor using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing or inhibiting activity at receptors such as, for example, the adrenergic alpha2A and/or the alpha2B receptors using the compounds and compositions disclosed herein.
申请公布号 US2014179706(A1) 申请公布日期 2014.06.26
申请号 US201314134120 申请日期 2013.12.19
申请人 MAP PHARMACEUTICALS, INC. 发明人 Armer Thomas;Kori Shashidhar;Wu Libo
分类号 C07D457/02;A61K9/00 主分类号 C07D457/02
代理机构 代理人
主权项 1. A fluoroergoline derivative composition suitable for use in the treatment of a disease, condition, or disorder selected from the group consisting of migraine, amyotrophic lateral sclerosis (ALS), Parkinson's disease, stress/anxiety, nausea, emesis, aggression, pain, neuropathic pain, sleeplessness, insomnia, restless leg syndrome and depression.
地址 Mountain View CA US